National Rural Utilities Cooperative Finance Corp
Change company Symbol lookup
Select an option...
NRUC National Rural Utilities Cooperative Finance Corp
UPS United Parcel Service Inc
BOLT Bolt Biotherapeutics Inc
EIX Edison International
EM Smart Share Global Ltd
WTW Willis Towers Watson PLC
DSU BlackRock Debt Strategies Fund Inc
TRTN-A Triton International Ltd
RNG RingCentral Inc
WFCF Where Food Comes From Inc
Go

Closing Price
$26.28
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.81
Day's Low
26.24
Volume
(Light)
Volume:
10,461

10-day average volume:
14,269
10,461

Cybin to Participate in the 11th Annual LifeSci Partners Corporate Access Event and H.C. Wainwright Bioconnect Conference

7:30 am ET December 21, 2021 (BusinessWire) Print

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeutics(TM)" is pleased to announce that Doug Drysdale, Cybin's Chief Executive Officer, will participate in two upcoming virtual investor conferences as follows:

11th Annual LifeSci Partners Annual Corporate Access Event, January 5-7, 2022

Mr. Drysdale will participate in a panel discussion titled "Psychedelics: More Than Just a Trip" on Wednesday, January 5, 2022 at 10:00 a.m. ET. Please click here to register and access the webcast.

H.C. Wainwright Bioconnect Conference, January 10-13, 2022

Mr. Drysdale will participate in a fireside chat at the H.C. Wainwright Bioconnect Conference being held virtually on Monday, January 10, 2022.

The fireside chat will be available on-demand beginning on January 10, 2022 at 7:00 a.m. ET. To listen to the event, please click here to register and access the webcast. The archived webcast will also be available on the Company's investor relations website on the Events & Presentations page.

About Cybin Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics(TM) by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211221005177/en/

SOURCE: Cybin Inc.

Investors & Media: 
Leah Gibson
Vice President, Investor Relations
Cybin Inc.
leah@cybin.com
comtex tracking

COMTEX_399343056/1006/2021-12-21T07:30:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.